Celastrol inhibits IL-6, IL-8, ICAM-1, and COX-2 cytokines production in IL-1β-induced orbital fibroblasts, which suppresses inflammation and inhibits the progression of GO (Li et al., 2016). Here, IL1B is linked to geroderma osteodysplastica.